☰

Manmeet Singh Ahluwalia, MD, MBA, FASCO - Publications

Affiliations: 
1995-2000 Maulana Azad Medical College 
 2003-2006 Fairview Hospital, Cleveland, OH 
 2006-2009 Roswell Park Comprehensive Cancer Center 
 2006-2009 Roswell Park Cancer Institute, Buffalo, NY, United States 
 2009-2021 The Cleveland Clinic, Cleveland, OH, United States 
 2009-2021 Cleveland Clinic Foundation, Cleveland, OH, United States 
 2009-2021 Case Western Reserve University, Cleveland Heights, OH, United States 
 2021- Miami Cancer Institute Baptist Health South Florida 
Area:
Neuro-Oncology, Brain Metastasis, Glioblastoma, Clinical trials
Website:
https://scholar.google.com/citations?user=YjLdmncAAAAJ
Tree Info Grants Similar researchers PubMed Report error

83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Lee J, Nicosia M, Hong ES, Silver DJ, Li C, Bayik D, Watson DC, Lauko A, Kay KE, Wang SZ, Johnson S, McGraw M, Grabowski MM, Kish DD, Desai AB, ... ... Ahluwalia MS, et al. Sex-biased T cell exhaustion drives differential immune responses in glioblastoma. Cancer Discovery. PMID 37378557 DOI: 10.1158/2159-8290.CD-22-0869  0.496
2023 La Rosa A, Gutierrez AN, Odia Y, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R. Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas. Neuro-Oncology Advances. 5: vdad074. PMID 37358937 DOI: 10.1093/noajnl/vdad074  0.376
2023 Tatineni V, O'Shea PJ, Saxena S, Khosla AA, Ozair A, Kotecha RR, Jia X, Rauf Y, Murphy ES, Chao ST, Suh JH, Peereboom DM, Ahluwalia MS. Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study. Cancers. 15. PMID 37296975 DOI: 10.3390/cancers15113015  0.734
2023 Alban TJ, Grabowski MM, Otvos B, Bayik D, Wang W, Zalavadia AH, Makarav V, Troike KM, McGraw M, Rabljenovic A, Lauko A, Neumann CK, Roversi G, Waite KA, Cioffi G, ... ... Ahluwalia MS, et al. The SNP rs755622 is associated with immune activation in glioblastoma. Jci Insight. PMID 37252795 DOI: 10.1172/jci.insight.160024  0.48
2023 Tatineni V, O'Shea PJ, Ozair A, Khosla AA, Saxena S, Rauf Y, Jia X, Murphy ES, Chao ST, Suh JH, Peereboom DM, Ahluwalia MS. First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases. Cancers. 15. PMID 37190312 DOI: 10.3390/cancers15082382  0.729
2023 Ozair A, Kumar A, Subash NR, Mirza S, Khosla AA, Ahluwalia M, Dahm P. Authorship Diversity in Global Evidence Synthesis in Urology: 1998-2022 Analysis of Cochrane Reviews. Bju International. PMID 36951507 DOI: 10.1111/bju.16010  0.691
2023 Grabowski MM, Watson DC, Chung K, Lee J, Bayik D, Lauko A, Alban T, Melenhorst JJ, Chan T, Lathia JD, Ahluwalia MS, Mohammadi AM. Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins. Medrxiv : the Preprint Server For Health Sciences. PMID 36945620 DOI: 10.1101/2023.03.09.23285970  0.53
2023 Ozair A, Bhat V, Alisch RS, Khosla AA, Kotecha RR, Odia Y, McDermott MW, Ahluwalia MS. DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets. Cancers. 15. PMID 36831683 DOI: 10.3390/cancers15041342  0.72
2023 Dhawan A, Manem VSK, Yeaney G, Lathia JD, Ahluwalia MS. EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status. Cancers. 15. PMID 36765632 DOI: 10.3390/cancers15030670  0.539
2023 Lehrer EJ, Kowalchuk RO, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Fakhoury KR, Rusthoven CG, Mathieu D, Trudel C, Malouff TD, Ruiz-Garcia H, Bonney P, ... ... Ahluwalia MS, et al. Concurrent administration of immune checkpoint inhibitors and single fraction stereotactic radiosurgery in patients with non-small cell lung cancer, melanoma, and renal cell carcinoma brain metastases is not associated with an increased risk of radiation necrosis over non-concurrent treatment: An international multicenter study of 657 patients. International Journal of Radiation Oncology, Biology, Physics. PMID 36690161 DOI: 10.1016/j.ijrobp.2023.01.017  0.306
2023 Kotecha R, Odia Y, Khosla AA, Ahluwalia MS. Key Clinical Principles in the Management of Glioblastoma. Jco Oncology Practice. OP2200476. PMID 36638331 DOI: 10.1200/OP.22.00476  0.787
2022 Khosla AA, Saxena S, Ozair A, Venur VA, Peereboom DM, Ahluwalia MS. Novel Therapeutic Approaches in Neoplastic Meningitis. Cancers. 15. PMID 36612116 DOI: 10.3390/cancers15010119  0.74
2022 Singh K, Saxena S, Khosla AA, McDermott MW, Kotecha RR, Ahluwalia MS. Update on the Management of Brain Metastasis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 36422836 DOI: 10.1007/s13311-022-01312-w  0.78
2022 Matsui JK, Perlow HK, Raj RK, Nalin AP, Lehrer EJ, Kotecha R, Trifiletti DM, McClelland S, Kendra K, Williams N, Owen DH, Presley CJ, Thomas EM, Beyer SJ, Blakaj DM, ... Ahluwalia MS, et al. Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors. Biomedicines. 10. PMID 36140312 DOI: 10.3390/biomedicines10092211  0.349
2022 Lauko A, Volovetz J, Turaga SM, Bayik D, Silver DJ, Mitchell K, Mulkearns-Hubert EE, Watson DC, Desai K, Midha M, Hao J, McCortney K, Steffens A, Naik U, Ahluwalia MS, et al. SerpinB3 drives cancer stem cell survival in glioblastoma. Cell Reports. 40: 111348. PMID 36103817 DOI: 10.1016/j.celrep.2022.111348  0.547
2022 Kutuk T, Kotecha R, Tolakanahalli R, Wieczorek DJJ, Lee YC, Ahluwalia MS, Hall MD, McDermott MW, Appel H, Gutierrez AN, Mehta MP, Tom MC. Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife Icon™ Stereotactic Radiosurgery for Brain Metastases. Cancers. 14. PMID 35884453 DOI: 10.3390/cancers14143392  0.445
2022 Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, et al. Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro-Oncology. PMID 35762249 DOI: 10.1093/neuonc/noac118  0.333
2022 Tewari S, Tom MC, Park DYJ, Wei W, Chao ST, Yu JS, Suh JH, Kilic S, Peereboom DM, Stevens GHJ, Lathia JD, Prayson R, Barnett GH, Angelov L, Mohammadi AM, ... Ahluwalia MS, et al. Sex-Specific Differences in Low Grade Glioma Presentation and Outcome. International Journal of Radiation Oncology, Biology, Physics. PMID 35667529 DOI: 10.1016/j.ijrobp.2022.05.036  0.472
2022 Kutuk T, Abrams KJ, Tom MC, Rubens M, Appel H, Sidani C, Hall MD, Tolakanahalli R, Wieczorek DJJ, Gutierrez AN, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R. Dedicated isotropic 3-D T1 SPACE sequence imaging for radiosurgery planning improves brain metastases detection and reduces the risk of intracranial relapse. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 173: 84-92. PMID 35662657 DOI: 10.1016/j.radonc.2022.05.029  0.457
2022 Kotecha R, Ahluwalia MS, Siomin V, McDermott MW. Surgery, Stereotactic Radiosurgery, and Systemic Therapy in the Management of Operable Brain Metastasis. Neurologic Clinics. 40: 421-436. PMID 35465884 DOI: 10.1016/j.ncl.2021.11.002  0.543
2022 Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, et al. Hypothetical Generalized Framework for a New Imaging Endpoint of Therapeutic Activity in Early Phase Clinical Trials in Brain Tumors. Neuro-Oncology. PMID 35380705 DOI: 10.1093/neuonc/noac086  0.31
2022 Kotecha R, Tonse R, Menendez MAR, Williams A, Diaz Z, Tom MC, Hall MD, Mehta MP, Alvarez R, Siomin V, Odia Y, Ahluwalia MS, McDermott MW. Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases. Scientific Reports. 12: 4567. PMID 35296750 DOI: 10.1038/s41598-022-08507-3  0.535
2021 Tonse R, Rubens M, Appel H, Tom MC, Hall MD, Odia Y, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R. Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance. Discover. Oncology. 12: 48. PMID 35201504 DOI: 10.1007/s12672-021-00445-2  0.534
2021 Tonse R, Rubens M, Appel H, Tom MC, Hall MD, Odia Y, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R. Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis. Neuro-Oncology Advances. 3: vdab166. PMID 34988451 DOI: 10.1093/noajnl/vdab166  0.455
2021 Taslimi S, Brar K, Ellenbogen Y, Deng J, Hou W, Moraes FY, Glantz M, Zacharia BE, Tan A, Ahluwalia MS, Khasraw M, Zadeh G, Mansouri A. Comparative Efficacy of Systemic Agents for Brain Metastases From Non-Small-Cell Lung Cancer With an EGFR Mutation/ALK Rearrangement: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology. 11: 739765. PMID 34950579 DOI: 10.3389/fonc.2021.739765  0.328
2021 Kutuk T, Tolakanahalli R, Williams A, Tom MC, Vadhan JD, Appel H, Hall MD, Wieczorek DJJ, Davis S, McDermott MW, Ahluwalia MS, Mehta MP, Gutierrez AN, Kotecha R. Impact of MRI timing on tumor volume and anatomic displacement for brain metastases undergoing stereotactic radiosurgery. Neuro-Oncology Practice. 8: 674-683. PMID 34777836 DOI: 10.1093/nop/npab047  0.502
2021 Kim AE, Wang GM, Waite KA, Elder S, Fine A, Ahluwalia MS, Brat D, Mehta MP, Page R, Dunbar E, Calderone HM, Robins DS, DeVitto R, Willmarth NE, Barnholtz-Sloan JS, et al. Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastases. Neuro-Oncology Practice. 8: 662-673. PMID 34777835 DOI: 10.1093/nop/npab042  0.321
2021 Tonse R, Townsend A, Rubens M, Siomin V, McDermott MW, Tom MC, Hall MD, Odia Y, Ahluwalia MS, Mehta MP, Kotecha R. Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States. Scientific Reports. 11: 22152. PMID 34773051 DOI: 10.1038/s41598-021-01641-4  0.459
2021 Wieczorek DJ, Kotecha R, Hall MD, Tom MC, Davis S, Ahluwalia MS, McDermott MW, Mehta MP, Gutierrez AN, Tolakanahalli R. Systematic evaluation and plan quality assessment of the Leksell® gamma knife® lightning dose optimizer. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. PMID 34696931 DOI: 10.1016/j.meddos.2021.08.006  0.355
2021 Brar K, Taslimi S, Ellenbogen Y, Deng J, Hou W, Moraes FY, Glantz M, Zacharia BE, Tan A, Ahluwalia MS, Khasraw M, Zadeh G, Mansouri A. Comparative efficacy of treatments for brain metastases from non-small-cell lung cancer without an EGFR-mutation/ALK-rearrangement: a systematic review and network meta-analysis. World Neurosurgery. PMID 34688937 DOI: 10.1016/j.wneu.2021.10.113  0.31
2021 Tonse R, Tom MC, Mehta MP, Ahluwalia MS, Kotecha R. Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases. Cancers. 13. PMID 34359583 DOI: 10.3390/cancers13153682  0.347
2021 Lee J, Kay K, Troike K, Ahluwalia MS, Lathia JD. Sex Differences in Glioblastoma Immunotherapy Response. Neuromolecular Medicine. PMID 33864598 DOI: 10.1007/s12017-021-08659-x  0.546
2021 Lauko A, Lo A, Ahluwalia MS, Lathia JD. Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors. Seminars in Cancer Biology. PMID 33640445 DOI: 10.1016/j.semcancer.2021.02.014  0.657
2021 Otvos B, Alban TJ, Grabowski MM, Bayik D, Mulkearns-Hubert EE, Radivoyevitch T, Rabljenovic A, Johnson S, Androjna C, Mohammadi AM, Barnett GH, Ahluwalia MS, Vogelbaum MA, Fecci PE, Lathia JD. Preclinical modeling of surgery and steroid therapy for glioblastoma reveals changes in immunophenotype that are associated with tumor growth and outcome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33542075 DOI: 10.1158/1078-0432.CCR-20-3262  0.564
2020 Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW, Fabiano AJ, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, et al. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 1537-1570. PMID 33152694 DOI: 10.6004/jnccn.2020.0052  0.331
2020 Tao W, Zhang A, Zhai K, Huang Z, Huang H, Zhou W, Huang Q, Fang X, Prager BC, Wang X, Wu Q, Sloan AE, Ahluwalia MS, Lathia JD, Yu JS, et al. SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells. Embo Molecular Medicine. e12291. PMID 33124191 DOI: 10.15252/emmm.202012291  0.486
2020 Soffietti R, Ahluwalia M, Lin N, Rudà R. Management of brain metastases according to molecular subtypes. Nature Reviews. Neurology. PMID 32873927 DOI: 10.1038/S41582-020-0391-X  0.361
2020 Zuccato JA, Aizer AA, Lee EQ, Ahluwalia MS, O'Halloran PJ, Mansouri A, Wen PY, Zadeh G. Highlights of the 2019 Society for Neuro-Oncology Inaugural Brain Metastases Conference: establishing a dedicated meeting to address an unmet need in the field. Neuro-Oncology Advances. 2: vdaa036. PMID 32793883 DOI: 10.1093/noajnl/vdaa036  0.497
2020 Lauko A, Rauf Y, Ahluwalia MS. Medical management of brain metastases. Neuro-Oncology Advances. 2: vdaa015. PMID 32793881 DOI: 10.1093/noajnl/vdaa015  0.496
2020 Alban TJ, Bayik D, Otvos B, Rabljenovic A, Leng L, Jia-Shiun L, Roversi G, Lauko A, Momin AA, Mohammadi AM, Peereboom DM, Ahluwalia MS, Matsuda K, Yun K, Bucala R, et al. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression. Frontiers in Immunology. 11: 1191. PMID 32625208 DOI: 10.3389/Fimmu.2020.01191  0.54
2020 Bayik D, Zhou Y, Park C, Hong C, Vail D, Silver DJ, Lauko A, Roversi G, Watson DC, Lo A, Alban TJ, McGraw M, Sorensen M, Grabowski MM, Otvos B, ... ... Ahluwalia MS, et al. Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner. Cancer Discovery. PMID 32300059 DOI: 10.1158/2159-8290.Cd-19-1355  0.526
2020 Suh JH, Kotecha R, Chao ST, Ahluwalia MS, Sahgal A, Chang EL. Current approaches to the management of brain metastases. Nature Reviews. Clinical Oncology. PMID 32080373 DOI: 10.1038/s41571-019-0320-3  0.338
2019 Peereboom DM, Alban TJ, Grabowski MM, Alvarado AG, Otvos B, Bayik D, Roversi G, McGraw M, Huang P, Mohammadi AM, Kornblum HI, Radivoyevitch T, Ahluwalia MS, Vogelbaum MA, Lathia JD. Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells. Jci Insight. PMID 31600167 DOI: 10.1172/jci.insight.130748  0.549
2019 Desai K, Hubben A, Ahluwalia M. The Role of Checkpoint Inhibitors in Glioblastoma. Targeted Oncology. PMID 31290002 DOI: 10.1007/s11523-019-00655-3  0.338
2019 Niranjan A, Lunsford LD, Ahluwalia MS. Targeted Therapies for Brain Metastases. Progress in Neurological Surgery. 34: 125-137. PMID 31096209 DOI: 10.1159/000493057  0.355
2019 Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NTN, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens G, et al. Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines. Neuro-Oncology. 21: 424-427. PMID 30883663 DOI: 10.1093/Neuonc/Noz034  0.306
2019 Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, Gatson NTN, Jordan JT, Khasraw M, Lassman AB, Maues J, Mrugala M, Raizer J, Schiff D, Stevens G, et al. Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1802085. PMID 30883246 DOI: 10.1200/Jco.18.02085  0.304
2019 Raghunath A, Desai K, Ahluwalia MS. Current Treatment Options for Breast Cancer Brain Metastases. Current Treatment Options in Oncology. 20: 19. PMID 30771009 DOI: 10.1007/s11864-019-0618-5  0.336
2019 Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, Peters S, Arvold ND, Harsh GR, Steeg PS, Chang SD. Brain metastases. Nature Reviews. Disease Primers. 5: 5. PMID 30655533 DOI: 10.1038/s41572-018-0055-y  0.364
2018 Kotecha R, Gondi V, Ahluwalia MS, Brastianos PK, Mehta MP. Recent advances in managing brain metastasis. F1000research. 7. PMID 30473769 DOI: 10.12688/f1000research.15903.1  0.354
2018 Alban TJ, Alvarado AG, Sorensen MD, Bayik D, Volovetz J, Serbinowski E, Mulkearns-Hubert EE, Sinyuk M, Hale JS, Onzi GR, McGraw M, Huang P, Grabowski MM, Wathen CA, Ahluwalia MS, et al. Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. Jci Insight. 3. PMID 30385717 DOI: 10.1172/jci.insight.122264  0.547
2018 Thapa B, Lauko A, Desai K, Venur VA, Ahluwalia MS. Novel Systemic Treatments for Brain Metastases From Lung Cancer. Current Treatment Options in Neurology. 20: 48. PMID 30259236 DOI: 10.1007/s11940-018-0533-2  0.331
2018 Lauko A, Thapa B, Venur VA, Ahluwalia MS. Management of Brain Metastases in the New Era of Checkpoint Inhibition. Current Neurology and Neuroscience Reports. 18: 70. PMID 30121715 DOI: 10.1007/s11910-018-0877-8  0.351
2018 Ahluwalia MS, Becker K, Levy BP. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer. The Oncologist. PMID 29650684 DOI: 10.1634/theoncologist.2017-0572  0.316
2018 Valiente M, Ahluwalia MS, Boire A, Brastianos PK, Goldberg SB, Lee EQ, Le Rhun E, Preusser M, Winkler F, Soffietti R. The Evolving Landscape of Brain Metastasis. Trends in Cancer. 4: 176-196. PMID 29506669 DOI: 10.1016/J.Trecan.2018.01.003  0.356
2018 Venur VA, Karivedu V, Ahluwalia MS. Systemic therapy for brain metastases. Handbook of Clinical Neurology. 149: 137-153. PMID 29307351 DOI: 10.1016/B978-0-12-811161-1.00011-6  0.482
2017 Thapa B, Borghei-Razavi H, M Mohammadi A, Ahluwalia M. An Excellent Clinical Outcome with Stereotactic Radiosurgery in a Geriatric Patient with Multiple and Recurrent Brain Metastases. Cureus. 9: e1979. PMID 29492368 DOI: 10.7759/cureus.1979  0.342
2017 Di Lorenzo R, Ahluwalia MS. Targeted therapy of brain metastases: latest evidence and clinical implications. Therapeutic Advances in Medical Oncology. 9: 781-796. PMID 29449898 DOI: 10.1177/1758834017736252  0.395
2017 Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V. Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017759589. PMID 29272161 DOI: 10.1200/JCO.2017.75.9589  0.333
2017 Venur VA, Funchain P, Kotecha R, Chao ST, Ahluwalia MS. Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 2: When and How to Use the New Systemic Agents. Oncology (Williston Park, N.Y.). 31. PMID 29071693  0.314
2017 Angelov L, Mohammadi AM, Bennett EE, Abbassy M, Elson P, Chao ST, Montgomery JS, Habboub G, Vogelbaum MA, Suh JH, Murphy ES, Ahluwalia MS, Nagel SJ, Barnett GH. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm. Journal of Neurosurgery. 1-17. PMID 28937324 DOI: 10.3171/2017.3.JNS162532  0.312
2017 Müller-Greven GM, Carlin C, Burgett ME, Ahluwalia MS, Lauko A, Nowacki AS, Herting CJ, Qadan MA, Bredel M, Toms SA, Lathia JD, Hambardzumyan D, Sarkaria JN, Hamerlik P, Gladson CL. Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28912141 DOI: 10.1158/1078-0432.Ccr-17-0249  0.525
2017 Venur VA, Funchain P, Kotecha R, Chao ST, Ahluwalia MS. Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 1: Diagnosis, Prognosis, Symptom Control, and Local Treatment. Oncology (Williston Park, N.Y.). 31. PMID 28812301  0.302
2017 Sharma M, Jia X, Ahluwalia M, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Murphy ES, Yu JS, Angelov L, Mohammadi AM. Cumulative Intracranial Tumor Volume and Number of Brain Metastasis as Predictors of Developing New Lesions after Stereotactic Radiosurgery for Brain Metastasis. World Neurosurgery. PMID 28735139 DOI: 10.1016/j.wneu.2017.07.048  0.312
2017 Shonka N, Venur VA, Ahluwalia MS. Targeted Treatment of Brain Metastases. Current Neurology and Neuroscience Reports. 17: 37. PMID 28326470 DOI: 10.1007/s11910-017-0741-2  0.356
2017 Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Suh JH, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Chao ST. The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases. Practical Radiation Oncology. PMID 28254368 DOI: 10.1016/j.prro.2017.01.001  0.343
2017 Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, et al. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016697144. PMID 28113019 DOI: 10.1200/JCO.2016.69.7144  0.305
2016 Venur VA, Ahluwalia MS. Targeted Therapy in Brain Metastases: Ready for Primetime? American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 35: e123-30. PMID 27249714 DOI: 10.14694/EDBK_100006  0.347
2016 Berghoff AS, Venur VA, Preusser M, Ahluwalia MS. Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 35: e116-22. PMID 27249713 DOI: 10.14694/EDBK_100005  0.342
2016 Silver DJ, Sinyuk M, Vogelbaum MA, Ahluwalia MS, Lathia JD. The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities. Neuro-Oncology. 18: 153-9. PMID 26264894 DOI: 10.1093/neuonc/nov157  0.544
2016 Venur VA, Ahluwalia MS. Prognostic scores for brain metastasis patients: use in clinical practice and trial design. Chinese Clinical Oncology. 4: 18. PMID 26112804 DOI: 10.3978/j.issn.2304-3865.2015.06.01  0.321
2016 Ahluwalia MS, Winkler F. Targeted and immunotherapeutic approaches in brain metastases. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 67-74. PMID 25993144 DOI: 10.14694/EdBook_AM.2015.35.67  0.337
2015 Wong ET, Toms SA, Ahluwalia MS. Technological Advances in the Treatment of Cancer: Combining Modalities to Optimize Outcomes. Clinical Advances in Hematology & Oncology : H&O. 13: 1-18. PMID 26862770  0.315
2015 Mehta MP, Ahluwalia MS. Whole-brain radiotherapy and stereotactic radiosurgery in brain metastases: what is the evidence? American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 35: e99-e104. PMID 25993245 DOI: 10.14694/EdBook_AM.2015.35.e99  0.348
2015 Hitomi M, Deleyrolle LP, Mulkearns-Hubert EE, Jarrar A, Li M, Sinyuk M, Otvos B, Brunet S, Flavahan WA, Hubert CG, Goan W, Hale JS, Alvarado AG, Zhang A, Rohaus M, ... ... Ahluwalia MS, et al. Differential connexin function enhances self-renewal in glioblastoma. Cell Reports. 11: 1031-42. PMID 25959821 DOI: 10.1016/J.Celrep.2015.04.021  0.504
2015 Venur VA, Peereboom DM, Ahluwalia MS. Current medical treatment of glioblastoma. Cancer Treatment and Research. 163: 103-15. PMID 25468228 DOI: 10.1007/978-3-319-12048-5_7  0.301
2014 Ahluwalia MS, Vogelbaum MV, Chao ST, Mehta MM. Brain metastasis and treatment. F1000prime Reports. 6: 114. PMID 25580268 DOI: 10.12703/P6-114  0.357
2014 Kondziolka D, Kalkanis SN, Mehta MP, Ahluwalia M, Loeffler JS. It is time to reevaluate the management of patients with brain metastases. Neurosurgery. 75: 1-9. PMID 24662510 DOI: 10.1227/NEU.0000000000000354  0.351
2014 Kondziolka D, Parry PV, Lunsford LD, Kano H, Flickinger JC, Rakfal S, Arai Y, Loeffler JS, Rush S, Knisely JP, Sheehan J, Friedman W, Tarhini AA, Francis L, Lieberman F, ... Ahluwalia MS, et al. The accuracy of predicting survival in individual patients with cancer. Journal of Neurosurgery. 120: 24-30. PMID 24160479 DOI: 10.3171/2013.9.Jns13788  0.474
2012 Huang P, Rani MR, Ahluwalia MS, Bae E, Prayson RA, Weil RJ, Nowacki AS, Hedayat H, Sloan AE, Lathia JD, Rich JN, Tipps R, Gladson CL. Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastoma. Cancer Research. 72: 1428-37. PMID 22396498 DOI: 10.1158/0008-5472.Can-11-2621  0.518
2012 Ahluwalia MS, Patel M, Peereboom DM. Role of tyrosine kinase inhibitors in the management of high-grade gliomas. Expert Review of Anticancer Therapy. 11: 1739-48. PMID 22050023 DOI: 10.1586/era.11.166  0.3
2010 Ahluwalia MS, de Groot J, Liu WM, Gladson CL. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies. Cancer Letters. 298: 139-49. PMID 20947248 DOI: 10.1016/j.canlet.2010.08.014  0.378
2010 Ahluwalia MS, Gladson CL. Progress on antiangiogenic therapy for patients with malignant glioma. Journal of Oncology. 2010: 689018. PMID 20379377 DOI: 10.1155/2010/689018  0.347
Show low-probability matches.